4D Molecular Therapeutics, Inc. short interest in 2022
In 2022, 4D Molecular Therapeutics, Inc.'s disclosed short interest ran from 4.40% of shares outstanding on 14 Jan 2022 to 6.40% on 30 Dec 2022, a change of +2.00 percentage points. The year's high was 9.10% on 14 Oct 2022 and its low 4.40% on 14 Jan 2022, averaging 5.91% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.80 days on 29 Apr 2022. Full history: 4D Molecular Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 4.40% (14 Jan 2022)
- End of year
- 6.40% (30 Dec 2022)
- Change
- +2.00 pp
- High
- 9.10% (14 Oct 2022)
- Low
- 4.40% (14 Jan 2022)
- Average
- 5.91%
- Highest days to cover
- 11.80 (29 Apr 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 4.40% | 8.41 | |
| 31 Jan 2022 | 4.87% | 5.91 | |
| 15 Feb 2022 | 5.17% | 6.33 | |
| 28 Feb 2022 | 5.56% | 8.83 | |
| 15 Mar 2022 | 5.53% | 7.33 | |
| 31 Mar 2022 | 5.59% | 10.87 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 5.90% | 10.27 | |
| 29 Apr 2022 | 6.09% | 11.80 | |
| 13 May 2022 | 5.85% | 7.61 | 10-Q filed, results (8-K) |
| 31 May 2022 | 6.15% | 8.62 | |
| 15 Jun 2022 | 6.60% | 8.24 | |
| 30 Jun 2022 | 5.47% | 3.09 | |
| 15 Jul 2022 | 5.29% | 9.60 | |
| 29 Jul 2022 | 5.02% | 10.91 | |
| 15 Aug 2022 | 4.82% | 10.46 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 4.63% | 9.44 | |
| 15 Sep 2022 | 4.49% | 7.73 | |
| 30 Sep 2022 | 4.86% | 2.69 | |
| 14 Oct 2022 | 9.10% | 9.01 | |
| 31 Oct 2022 | 8.95% | 7.21 | |
| 15 Nov 2022 | 8.33% | 4.29 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 7.08% | 2.37 | |
| 15 Dec 2022 | 5.72% | 3.92 | |
| 30 Dec 2022 | 6.40% | 5.26 |
See also: 4D Molecular Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.